Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.7 USD | +1.24% | +0.19% | +56.07% |
12:00am | Enliven Therapeutics, Inc.(NasdaqGS:ELVN) added to S&P Pharmaceuticals Select Industry Index | CI |
11/06 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ENLIVEN THERAPEUTICS, INC. | Bio Therapeutic Drugs | +0.75% | +0.19% | +56.07% | +9.92% | - | 1.01B |
Technical Rankings Surperformance
- Stock Market
- Equities
- ELVN Stock
- Charts Enliven Therapeutics, Inc.
- Comparison Chart